EUVIMEDEUVIMED entdecken
Crossref

To Evaluate Efficacy of Intralesional Platelet Rich Plasma in Patients with Plantar Fasciitis

Sanjiv Kumar, Chethan Channaveera, Satyaranjan Sethi, Ranjan Kumar Wadhwa, Vijender Anand

Journal of the American Podiatric Medical Association · 2025

DOI: 10.7547/24-161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Podiatric Medical Association, 2025. Verfasst von Sanjiv Kumar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, VMMC and Safdarjung Hospital, New Delhi 110029, India. Hauptthemen laut MEDLINE: Fasciitis, Plantar, Platelet-Rich Plasma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Plantar fasciitis (PF) is one of the most common causes of heel pain that affecting 10 % of the general population. Platelet rich plasma (PRP) has been demonstrated to be helpful in managing PF and reducing plantar facia thickness (PFT). This study objective was to know the effect and efficacy of ultrasound (USG) guided intralesional PRP in PF in relation to pain, PFT and foot function index (FFI). METHODS: A prospective interventional study was conducted in a tertiary care hospital on eighty-five diagnosed cases of unilateral PF. All patients had undergone pain intensity assessment by visual analogue scale (VAS), FFI, and USG examination of PFT after USG guided intralesional PRP injection was assessed at baseline (0 weeks), 2 weeks and 6 weeks. RESULTS: Following USG guided intralesional PRP injection, a statistically significant decrease was noted in plantar fascia thickness (PFT) from baseline 0 (week) 6.592mm ± 0.51mm to 5.169mm ± 0.39mm and reduced to 4.07mm ± 0.39mm at 2nd week and 6th week, respectively (P value < 0.001). A statistically significant reduction of VAS score was noted which reduced from 8.647 ± 0.55 to 5.588 ± 1.13 (2nd week) and further reduced to 1.21 ± 1.06 at the end of 6 weeks (p value < 0.001). Mean FFI in our study at baseline was 85.494 ± 6.55, at 2 weeks mean FFI was 49.341 ± 7.277 and the end of 6 week it reduced to 24.235 ± 1.608 (P value < 0.001) statistically significant decrease was noted. CONCLUSIONS: PRP injection helps in the reduction of heel pain (VAS), reduction in PFT, and improvement in all domains of FFI, leading to enhancement of quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fasciitis, PlantarPlatelet-Rich PlasmaHumansFemaleInjections, IntralesionalProspective StudiesMalePain MeasurementTreatment OutcomeMiddle AgedAdultUltrasonography, InterventionalAged

Autor:innen und Institutionen

  • Department of Physical Medicine and Rehabilitation, VMMC and Safdarjung Hospital, New Delhi 110029, India.
  • Department of Physical Medicine and Rehabilitation, Employee's State Insurance Corporation Medical College and Hospital, Faridabad 121001, Haryana, India.

Zitieren

APA

Kumar, S., Channaveera, C., Sethi, S., Wadhwa, R. K., & Anand, V. (2025). To Evaluate Efficacy of Intralesional Platelet Rich Plasma in Patients with Plantar Fasciitis. Journal of the American Podiatric Medical Association. https://doi.org/10.7547/24-161

Vancouver

Kumar S, Channaveera C, Sethi S, Wadhwa RK, Anand V. To Evaluate Efficacy of Intralesional Platelet Rich Plasma in Patients with Plantar Fasciitis. Journal of the American Podiatric Medical Association. 2025. doi:10.7547/24-161

BibTeX
@article{Kumar2025,
  author = {Kumar, Sanjiv and Channaveera, Chethan and Sethi, Satyaranjan and Wadhwa, Ranjan Kumar and Anand, Vijender},
  title = {To Evaluate Efficacy of Intralesional Platelet Rich Plasma in Patients with Plantar Fasciitis},
  journal = {Journal of the American Podiatric Medical Association},
  year = {2025},
  doi = {10.7547/24-161}
}
Kostenlos starten →